Stress Disorders, Post-TraumaticIRESCNCT07422077
Impact of ERCS on Perceived Stress in Patients Hospitalized in the Post-resuscitation Rehabilitation Service
A study testing ERCS sessions in people with Stress Disorders, Post-Traumatic, run by Hôpital Européen Marseille at 1 site in France.
Trial summary
Surviving an intensive care unit hospitalization (ICU) can be the beginning of a long rehabilitation journey, hindered by symptoms of stress, PTSD, anxiety, and depression. In order to improve the care of these patients, it's essential to explore effective non-pharmacological approaches to reduce stress. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Stress Disorders, Post-Traumatic
- What is being tested?
- ERCS sessions
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 38 participants
- Where
- 1 siteFrance
- Study dates
- 8 Dec 2025to 8 Sep 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Aged ≥ 18 years
- Hospitalized adults in a Post-Intensive Care Rehabilitation Unit (SRPR)
- Having given free and informed written consent
Who cannot join
- Pregnant or breastfeeding woman
- Persons deprived of their liberty by a judicial or administrative decision.
- Persons who are subject to a legal protection measure or who are unable to express their consent.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Hôpital Européen Marseille
Marseille
Myriam BENNANI, 0413428351, m.bennani@hopital-europeen.fr
Gina BOUVIER
About this study
Official title: Impact of Energy Resonance by Skin Stimulation on Perceived Stress in Patients Hospitalized in the Post-resuscitation Rehabilitation Service
Surviving an intensive care unit hospitalization (ICU) can be the beginning of a long rehabilitation journey, hindered by symptoms of stress, PTSD, anxiety, and depression. In order to improve the care of these patients, it's essential to explore effective non-pharmacological approaches to reduce stress. Many non-drug techniques are being developed to alleviate the physical and psychological pain of patients.
Energy Resonance by Skin Stimulation (ERCS) is a noninvasive method of soothing and supporting the patient. This technique is based on the energetic principles of traditional Chinese medicine. It relies on a "listening contact" through the stimulation of cutaneous points to create resonance and transmit vibrational and wave messages in the tissues. ERCS has various applications, whether for the management of acute or chronic pain, emotional disorders such as fear, anxiety, and depression.
Our study aims to assess the effects of ERCS on the perceived stress of patients hospitalized in the post-ICU rehabilitation service. By demonstrating its potential impact on both physical and psychological recovery, this research could support the integration of RESC into care protocols and open new perspectives for stress management in hospital settings
- Conditions
- Stress Disorders, Post-Traumatic
- Being tested
- ERCS sessions
- Medical subject headings
- Stress Disorders, Post-Traumatic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ERCS sessionsOther
Two ERCS sessions spaced one week apart, on Day 0 and Day 7
| Study group | Role | What they receive |
|---|---|---|
| Patients hospitalized in the post-ICU rehabilitation service. | Other | Not described Receives: Other: ERCS sessions |
What is being measured
The primary outcome is the main question the study is designed to answer.
Difference in the level of perceived stress by the patient before and immediately after the second RESC session (two sessions on day 0 and day 7), measured using a Visual Analog Scale (VAS).
Measured: Day 0 and day 7
Secondary outcomes (6)
Daily evolution of perceived stress (VAS) between Day 0 and Day 7
Measured: Day 0 and day 7
Difference in pain (VAS) between, before and after each session
Measured: Day 0 and day 7
Measurement in clinical parameters before and after each session (respiratory rate breaths per minute/bpm; heart rate beats per minute/bpm; blood pressure millimeters of mercury, mmHg; oxygen saturation percentage, %)
Measured: Day 0 and day 7
Anxiety score (COVI scale) before and after each session
Measured: Day 0 and day 7
Measurement of the patient's physical symptoms during the session using a binary scale for each symptom at the end of each RESC session
Measured: Day 0 and day 7
Duration of each ERCS session
Measured: Day 0 and day 7
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Feb 2026
- Study start8 Dec 2025
- Primary completion8 Jun 2027 (estimated)
- Study completion8 Sep 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stress Disorders, Post-TraumaticStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 38 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hôpital Européen Marseille
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07422077
- Sponsor's protocol ID
- 25-04
- Acronym
- IRESC
- Status last verified
- Feb 2026
- First submitted
- 1 Dec 2025
- Last updated
- 19 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Energy Resonance by Skin Stimulation on Perceived Stress in Patients Hospitalized in the Post-resuscitation Rehabilitation Service
- ClinicalTrials.gov ID
- NCT07422077
- Acronym / sponsor ID
- IRESC / 25-04
- Conditions
- Stress Disorders, Post-Traumatic
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 38 participants (estimated)
- Lead sponsor
- Hôpital Européen MarseilleUniversity, hospital or other
- Study start
- 8 Dec 2025 (actual)
- Primary completion
- 8 Jun 2027 (estimated)
- Study completion
- 8 Sep 2027 (estimated)
- First posted
- 19 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Surviving an intensive care unit hospitalization (ICU) can be the beginning of a long rehabilitation journey, hindered by symptoms of stress, PTSD, anxiety, and depression. In order to improve the care of these patients, it's essential to explore effective non-pharmacological approaches to reduce stress. Many non-drug techniques are being developed to alleviate the physical and psychological pain of patients.
Energy Resonance by Skin Stimulation (ERCS) is a noninvasive method of soothing and supporting the patient. This technique is based on the energetic principles of traditional Chinese medicine. It relies on a "listening contact" through the stimulation of cutaneous points to create resonance and transmit vibrational and wave messages in the tissues. ERCS has various applications, whether for the management of acute or chronic pain, emotional disorders such as fear, anxiety, and depression.
Our study aims to assess the effects of ERCS on the perceived stress of patients hospitalized in the post-ICU rehabilitation service. By demonstrating its potential impact on both physical and psychological recovery, this research could support the integration of RESC into care protocols and open new perspectives for stress management in hospital settings
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients hospitalized in the post-ICU rehabilitation service. | Other | Other: ERCS sessions |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Aged ≥ 18 years
- Hospitalized adults in a Post-Intensive Care Rehabilitation Unit (SRPR)
- Having given free and informed written consent
Key exclusion criteria (3 listed)
- Pregnant or breastfeeding woman
- Persons deprived of their liberty by a judicial or administrative decision.
- Persons who are subject to a legal protection measure or who are unable to express their consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ERCS sessionsTwo ERCS sessions spaced one week apart, on Day 0 and Day 7 | Other | Patients hospitalized in the post-ICU rehabilitation service. |
Primary outcome
Difference in the level of perceived stress by the patient before and immediately after the second RESC session (two sessions on day 0 and day 7), measured using a Visual Analog Scale (VAS).
Time frame: Day 0 and day 7
6 secondary outcomes
Daily evolution of perceived stress (VAS) between Day 0 and Day 7
Time frame: Day 0 and day 7
Difference in pain (VAS) between, before and after each session
Time frame: Day 0 and day 7
Measurement in clinical parameters before and after each session (respiratory rate breaths per minute/bpm; heart rate beats per minute/bpm; blood pressure millimeters of mercury, mmHg; oxygen saturation percentage, %)
Time frame: Day 0 and day 7
Anxiety score (COVI scale) before and after each session
Time frame: Day 0 and day 7
Measurement of the patient's physical symptoms during the session using a binary scale for each symptom at the end of each RESC session
Time frame: Day 0 and day 7
Duration of each ERCS session
Time frame: Day 0 and day 7
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Stress Disorders, Post-Traumatic
Recruiting
NightWare and Cardiovascular Health in Women With PTSD
Post Traumatic Stress Disorder, Cardiovascular Diseases
Not yet recruiting
A Transdiagnostic Sleep Health Intervention for Veterans With PTSD
Stress Disorders, Post-Traumatic, Sleep Initiation and Maintenance Disorders
Not yet recruitingPhase 3
Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol
Post-Traumatic Stress Disorder, PTSD
RecruitingPhase 4
The Effects of Orexin Antagonism on Fear Extinction in PTSD
Insomnia, PTSD
Recruiting
Advancing Skills Through Consultation, Education, and Novel Technologies
PTSD - Post Traumatic Stress Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ERCS sessions in people with Stress Disorders, Post-Traumatic, run by Hôpital Européen Marseille at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 19 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Myriam BENNANI (0413428351, m.bennani@hopital-europeen.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Difference in the level of perceived stress by the patient before and immediately after the second RESC session (two sessions on day 0 and day 7), measured using a Visual Analog Scale (VAS). (time frame: Day 0 and day 7). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2026.